Atalay Demiray, MD, MSc
he/him/his
DownloadHi-Res Photo
Cards
Education
MSc
Erasmus University, Health Economics, Policy and Law (2023)
Erasmus University, Health Economics, Policy and Law (2023)
MD
Koc University, Medicine (2022)
Koc University, Medicine (2022)
BA
Koc University, International Relations (2021)
Koc University, International Relations (2021)
Contact Info
Publications Overview
- 22 Publications
- 646 Citations
Education
MSc
Erasmus University, Health Economics, Policy and Law (2023)
Erasmus University, Health Economics, Policy and Law (2023)
MD
Koc University, Medicine (2022)
Koc University, Medicine (2022)
BA
Koc University, International Relations (2021)
Koc University, International Relations (2021)
Contact Info
Publications Overview
- 22 Publications
- 646 Citations
Education
MSc
Erasmus University, Health Economics, Policy and Law (2023)
Erasmus University, Health Economics, Policy and Law (2023)
MD
Koc University, Medicine (2022)
Koc University, Medicine (2022)
BA
Koc University, International Relations (2021)
Koc University, International Relations (2021)
Contact Info
Publications Overview
- 22 Publications
- 646 Citations
About
Copy Link
Biography
Atalay Demiray, MD, MSc, is a PhD candidate in Health Policy and Management (Economics Track) at the Yale School of Public Health. A physician and decision scientist, his research sits at the intersection of health economics, decision modeling, and health policy — applying microsimulation and cost-effectiveness analysis to tobacco regulation, maternal and infant health, comparative health systems, women's health, and the regulation of artificial intelligence in medicine.
At Yale, he co-developed and calibrated the Smoking, E-cigarette & Pregnancy (SEP) microsimulation in Prof. Jamie Tam's research group, projecting the long-term health and economic effects of a proposed federal nicotine product standard. He serves as a statistical consultant at the Yale University Library's StatLab, supporting clinical and biomedical researchers across the university, and has been a teaching fellow for graduate courses in health economics and cost-effectiveness analysis.
A first-generation college graduate from Türkiye, he is a committed advocate for diversity and global health equity. His master's thesis on the regulation of artificial intelligence in medicine was awarded Thesis of the Year in the Netherlands. He aims to leverage rigorous quantitative methods and emerging technologies to improve public health outcomes and advance health equity worldwide.
Last Updated on June 17, 2026.
Education & Training
- MSc
- Erasmus University, Health Economics, Policy and Law (2023)
- MD
- Koc University, Medicine (2022)
- BA
- Koc University, International Relations (2021)
Research
Copy Link
Overview
Public Health Interests
Health Economics; Health Policy; Maternal & Child Health; Modeling; Non-Communicable Diseases; Regulatory Affairs; Statistical Computing; Survival Analysis; Women's Health
ORCID
0000-0001-5503-5305- View Lab Website
Personal Website
Research at a Glance
Publications Timeline
A big-picture view of Atalay Demiray's research output by year.
22Publications
646Citations
Publications
2026
A comparison of long-term maternal mortality associated with pathologic placental separation: Highlighting possible trends and mechanisms
Jasani S, Demiray A, Stevenson J, Krawiec C. A comparison of long-term maternal mortality associated with pathologic placental separation: Highlighting possible trends and mechanisms. PLOS ONE 2026, 21: e0338586. PMID: 42030233, PMCID: PMC13108790, DOI: 10.1371/journal.pone.0338586.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsPlacental separationAssociated with significant morbidityFollow-up periodAssociated with retentionLong-term complicationsLong-term mortalityMaternal mortalityHealth outcomesVaginal deliveryMortality riskObstetric managementPlacental abruptionElevated riskNormal deliverySignificant morbidityAcute complicationsDemographic factorsCox regressionPlacental retentionMortality rateAbruptionMortalityComplicationsRiskPatients
2024
Beyond “business as usual”: lessons from FIFA for fair benefit-sharing in global health
Wahl B, Butin G, Gombe S, Demiray A, Schwalbe N. Beyond “business as usual”: lessons from FIFA for fair benefit-sharing in global health. Health Affairs Scholar 2024, 2: qxae068. PMID: 39050554, PMCID: PMC11267394, DOI: 10.1093/haschl/qxae068.Peer-Reviewed Original ResearchCitationsAltmetricConceptsLegal frameworkEquitable data sharingInternal buy-inTraining compensationBenefit-sharing modelAdequate compensationData sharingGlobal healthHealth surveillance dataEconomic contextPublic health surveillance dataFIFAAssociation footballMiddle-income countriesPandemic preventionCompensationResponse activitiesBusinessBuy-inIncentivizing data sharingPandemic periodPaymentFrameworkHealthAgencies
2023
Tirzepatide decreases systolic and diastolic blood pressure
Copur S, Demiray A, Cherney D, Tuttle K, Kanbay M. Tirzepatide decreases systolic and diastolic blood pressure. European Journal Of Internal Medicine 2023, 114: 135-137. PMID: 37045710, DOI: 10.1016/j.ejim.2023.04.005.Peer-Reviewed Original ResearchCitationsAltmetricThe use of extracorporeal membrane oxygenation in COVID-19: a systematic review
Zavalichi M, Ionescu G, Georgescu C, Mihaescu A, Cimpoesu C, Cimpoesu G, Zavalichi S, Stătescu C, Demiray A, Kanbay M, Covic A, Nistor I. The use of extracorporeal membrane oxygenation in COVID-19: a systematic review. Archives Of Medical Science 2023, 21: 897-918. PMID: 40741272, PMCID: PMC12305791, DOI: 10.5114/aoms/152022.Peer-Reviewed Original ResearchCitationsAltmetricConceptsAcute respiratory distress syndromeCochrane Central RegisterCOVID-19 patientsSurvival ratePulmonary embolismCochrane Central Register of Controlled TrialsExtracorporeal membrane oxygenationCentral Register of Controlled TrialsRespiratory distress syndromeSARS-CoV-2Acute kidney injuryRegister of Controlled TrialsSystematic reviewEffects of SARS-CoV-2Acute myocardial infarctionECMO useMajor bleedingCardiac impairmentDistress syndromeMembrane oxygenationOrgan dysfunctionKidney injuryAdverse eventsPeripheral bleedingOrgan perfusionEndocrinological disorders in acute kidney injury: an often overlooked field of clinical research
Copur S, Demiray A, Basile C, Kanbay M. Endocrinological disorders in acute kidney injury: an often overlooked field of clinical research. Journal Of Nephrology 2023, 36: 885-893. PMID: 36652168, DOI: 10.1007/s40620-022-01554-z.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsAcute kidney injuryAtrial natriuretic peptideConsequences of acute kidney injuryEffect of acute kidney injuryEndocrinological outcomesEndocrinological consequencesKidney injuryOutcomes of acute kidney injuryAtrial natriuretic peptide administrationActive form of vitamin DEuthyroid sick syndromeBone mineral disordersExcretion of insulinLarge-scale randomized controlled trialsNeuro-humoral mechanismsProduction of erythropoietinRandomized Controlled TrialsAcid-base disordersThyroid dysfunctionNatriuretic peptideNeurological outcomeSick syndromeSerum electrolytesEndocrinological disordersVitamin D
2022
Transition from locally developed, faculty-written (LFW) examinations to the National Board of Medical Examiners (NBME) subject examinations in clinical medical education
Demiray A, Öztosun Ç, Acar S, Sakarya S, Gürsoy T, Ata B. Transition from locally developed, faculty-written (LFW) examinations to the National Board of Medical Examiners (NBME) subject examinations in clinical medical education. SN Social Sciences 2022, 2: 200. DOI: 10.1007/s43545-022-00510-9.Peer-Reviewed Original ResearchConceptsNational Board of Medical ExaminersClinical medical educationMedical educationNational BoardStudents' scoresClinical clerkshipsNational Board of Medical Examiners subject examStudent gradesUnweighted kappa valuesStudent feedbackInternal medicine clerkshipBoard of Medical ExaminersSubject examinationAssessment of knowledgeNational Board of Medical Examiners subject examinationContent validityNational Board of Medical Examiners (NBME) subject examinationMedicine clerkshipSchool of MedicineMedical schoolsCohen's kappa coefficientSeventy-five studentsUniversity School of MedicineNon-EnglishInterrater agreementUric acid in metabolic syndrome: Does uric acid have a definitive role?
Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: Does uric acid have a definitive role? European Journal Of Internal Medicine 2022, 103: 4-12. PMID: 35508444, DOI: 10.1016/j.ejim.2022.04.022.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSerum uric acidSerum uric acid levelsChronic kidney diseaseMetabolic syndromeGut microbiotaUric acidGenetic variabilityCardiovascular diseaseEpigenetic changesMetabolic pathwaysNon-alcoholic fatty liver diseaseFatty liver diseaseAsymptomatic hyperuricemiaPathophysiological mechanismsVitamin D.Kidney diseaseLiver diseaseRisk factorsOptimal target levelOxidative stressBeneficial effectsDiseaseGenomeHyperuricemiaSyndromeThe Use of Healthy Eating Index 2015 and Healthy Beverage Index for Predicting and Modifying Cardiovascular and Renal Outcomes
Ertuglu L, Demiray A, Afsar B, Ortiz A, Kanbay M. The Use of Healthy Eating Index 2015 and Healthy Beverage Index for Predicting and Modifying Cardiovascular and Renal Outcomes. Current Nutrition Reports 2022, 11: 526-535. PMID: 35476188, DOI: 10.1007/s13668-022-00415-2.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsHealthy Eating IndexHealthy Beverage IndexDiet Quality IndexHEI-2015Health outcomesAssociation of HEI-2015Negative health outcomesQuality IndexFood intake qualityType 2 diabetes mellitusEating IndexNutrient groupsLong-term outcomesDietary guidelinesChronic kidney diseaseHealth markersHealthy dietDietary patternsMeasure adherenceHealthyModifiable cardiovascularIntake qualityRenal outcomesInflammatory markersMetabolic syndromeCardiorenal Metabolic Consequences of Nighttime Snacking: Is it an Innocent Eating Behavior?
Kanbay M, Copur S, Demiray A, Tuttler K. Cardiorenal Metabolic Consequences of Nighttime Snacking: Is it an Innocent Eating Behavior? Current Nutrition Reports 2022, 11: 347-353. PMID: 35195849, DOI: 10.1007/s13668-022-00403-6.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCardiorenal outcomesNighttime eatingElevated blood pressurePotential therapeutic alternativeMetabolic syndromeMetabolic outcomesTherapeutic alternativePathophysiological mechanismsHormone levelsPathophysiological basisBlood pressureEating behaviorsCellular regenerationWeight gainCircadian rhythmOutcomesEatingSodium–glucose cotransporter inhibition in polycystic kidney disease: fact or fiction
Afsar B, Afsar R, Demiray A, Altay S, Korkmaz H, Yildiz A, Covic A, Ortiz A, Kanbay M. Sodium–glucose cotransporter inhibition in polycystic kidney disease: fact or fiction. Clinical Kidney Journal 2022, 15: 1275-1283. PMID: 35756735, PMCID: PMC9217633, DOI: 10.1093/ckj/sfac029.Peer-Reviewed Original ResearchCitationsAltmetricConceptsAutosomal dominant polycystic kidney disease patientsAutosomal dominant polycystic kidney diseaseSodium-glucose cotransporterSGLT2 inhibitorsPolycystic kidney diseaseKidney diseaseSodium-glucoseSodium-glucose cotransporter inhibitionSafety of SGLT2 inhibitorsKidney function preservationHereditary kidney diseaseDominant polycystic kidney diseaseCardiovascular safety trialsDiverse clinical situationsPathogenesis of autosomal dominant polycystic kidney diseasePost Hoc AnalysisCotransporter inhibitionBlood glucose levelsMitochondrial dysfunctionFunction preservationPreclinical studiesSafety trialsChronic inflammationCardiovascular protective activitiesClinical trials
Links
Copy Link
Related Links
Get In Touch
Copy Link
Contacts
Locations
Public Health Modelling Unit
Academic Office
350 George Street
New Haven, CT 06511
Social Media